Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Cephalometric measurement points. by Lijuan Liu (136685)

Subjects:

Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. by Cristina Dolciotti (16317330)

Subjects:

Schematic diagram of experimental injector size. by Lei Bai (631944)

Subjects:

Fabric anisotropy evolution of numerical samples with different shapes and sizes. by Yongfeng Zhu (7361045)

Subjects:

Stress concentration factor value in the numerical samples with different shapes and sizes. by Yongfeng Zhu (7361045)

Subjects:

Deviatoric stress-strain curves of numerical samples composed of elongated ellipsoids with different particle morphologies and particle sizes. by Yongfeng Zhu (7361045)

Subjects:

Average contact force and percentage of strong contact force under different conditions: (a) different particle shapes, (b) different particle sizes. by Yongfeng Zhu (7361045)

Subjects:

The force chain distributions of different numerical samples composed of elongated ellipsoids with different particle morphologies and particle sizes before shearing and after load... by Yongfeng Zhu (7361045)

Subjects:

<i>Tillandsia utriculata</i> death rate data by size class. by Alexandra M. Campbell (3284094)

Subjects:

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the two groups WAD grades 2 and 3. by Anneli Peolsson (7867601)

Subjects:

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Subjects:

Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

The CDF of normal and tangential contact forces in numerical specimens after compression considering different particle morphologies: (a) normal contact force; (b) tangential conta... by Yongfeng Zhu (7361045)

Subjects:

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

Summary of five key points guiding the Safe Steps evaluation and implementation. by Esario IV Daguman (21474116)

Subjects:

Selection of soil particle sampling points. by Xueting Ma (390540)

Subjects:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Study-related adverse events. by Benjamin R. Lewis (22279166)

Subjects: